Help On Topical Finasteride 0.3%
    Finasteride/Dutasteride 6/3/2024

    At a glance
    In this question or advice post, the primary subjects mentioned are
    💧 Minoxidil (topical) 3% daily since 2021
    💧 Finasteride (topical) 0.3% daily
    💧 Progesterone (topical) 1% daily
    💧 Hydrocortisone butyrate (topical) 0.1% daily
    💧 Ketoconazole (topical) 0.5% daily
    💊 Ajuga reptans supplement (oral) daily since January 2023
    the tone is 😐 neutral.

    Other terms

    A user is seeking advice on a new topical hair loss treatment containing Minoxidil 3%, Finasteride 0.3%, Progesterone 1%, Hydrocortisone butyrate 0.1%, and Ketoconazole 0.5%. They are concerned about the systemic absorption of Finasteride and plan to do blood tests and a spermiogram before starting.
    View this post in the Community →

    Similar Community Posts Join

    5 / 1000+ results

    Related Research

    6 / 1000+ results
      General Dermatology: Comprehensive Overview of Dermatological Conditions

      research General Dermatology

      January 2017 in “Springer eBooks”
      The document explains various skin conditions and their treatments.
      Compounding as a Current Therapeutic Option in Dermatology

      research Compounding as a Current Therapeutic Option in Dermatology

      1 citations , October 2013 in “Actas Dermo-Sifiliográficas”
      Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.
      Hair Loss in Hospital Medicine: A Practical Guide

      research Hair loss in hospital medicine: a practical guide

      3 citations , July 2012 in “British journal of hospital medicine”
      The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.
      Reporting on Adverse Clinical Events

      research Reporting on Adverse Clinical Events

      March 2021 in “Clin-Alert”
      The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.